Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway

Galectin-9 is a widely expressed protein that is involved in immune regulation and tumorpathogenesis and serves as a marker of a poor prognosis in various types of cancers. However, the clinical impact and the precise mechanism by which this protein contributes to colon tumor progression are unclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Sun, Jintang, Ma, Chao, Gao, Wenjuan, Song, Bingfeng, Xue, Hao, Chen, Weiliang, Chen, Xi, Zhang, Yun, Shao, Qianqian, Wang, Qingjie, Zhao, Lei, Liu, Jia, Wang, Xiuwen, Wang, Huayang, Yang, Meixiang, Qu, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814049/
https://www.ncbi.nlm.nih.gov/pubmed/27028892
http://dx.doi.org/10.1371/journal.pone.0152599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814049/
https://www.ncbi.nlm.nih.gov/pubmed/27028892
http://dx.doi.org/10.1371/journal.pone.0152599

Ejemplares similares